Table 5.
Management of constipation in PSP/CBS.
| 1. Non-pharmacologic therapy |
| a. Increased physical activity |
| b. Adequate hydration until suppertime to minimize nocturnal trips to void |
| c. Fiber supplementation |
| d. Minimize |
| i. Anticholinergics |
| ii. Amantadine |
| iii. Opiates |
| 2. Pharmacologic therapy |
| a. Stool softener, docusate starting at 100 mg daily titrated weekly to 100 mg TID |
| b. Osmotic laxatives |
| i. Polyethylene glycol |
| ii. Magnesium citrate |
| iii. Lactulose |
| iv. OTC enema preparations of saline or other hyperosmolar salts |
| c. Stimulants for very short-term use |
| i. Bisacodyl |
| ii. Senna |
| d. Prescription medications for refractory cases |
| i. Linaclotide (guanylate cyclase C agonist) |
| ii. Prucalopride (selective 5-HT4 receptor agonist) |